SIGMA is Becoming GlucoseTech
First, thank you.
Your engagement, feedback, and trust over the years have helped shape SIGMA into what it is today. Everything we've built has been guided by clinicians like you who care deeply about delivering practical, evidence-based care.
If SIGMA has felt a little quieter lately, it's because we've been working behind the scenes on what comes next.
In just a few weeks, SIGMA (cgmonitoring.net) will relaunch as GlucoseTech (glucosetech.com) — a modern, clinician-focused platform designed to make it even easier to access timely, clinically relevant glucose sensing resources.
While our name is changing, our mission is not.
We remain committed to helping clinicians confidently integrate glucose sensing technology into real-world care through evidence-based education and resources.
What's changing - and why it matters
One important update: we're removing membership requirements.
This decision reflects our belief that high-quality glucose education should be easy to access, share, and apply — without barriers. Opening access will help us support more clinicians while continuing to deliver depth, clarity, and credibility.
With GlucoseTech, you'll be able to:
- Find what you need faster with a redesigned site, improved navigation, and better search
- Access resources instantly - no login required
- Discover tailored content specific to your specialty and experience level
- Stay current with more frequent content updates and newsletters
SIGMA will remain fully available until GlucoseTech goes live, ensuring uninterrupted access to all current resources. Once the new site launches, visitors to SIGMA will be automatically redirected to the new GlucoseTech platform.
Thank you for being part of the SIGMA community.
We’re excited to bring you the next chapter of glucose-informed care—and to welcome you to GlucoseTech.
